Christos Proukakis

Dr. Christos Proukakis

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2024 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
MSMoritz Smolka
Moritz Smolka
LPLuis F. Paulin
Luis F. Paulin
CGChristopher M. Grochowski
Christopher M. Grochowski
DHDominic W. Horner
Dominic W. Horner
MMMedhat Mahmoud
Medhat Mahmoud
FSFritz Sedlazeck
Fritz Sedlazeck
Calling structural variations (SVs) is technically challenging, but using long reads remains the most accurate way to identify complex genomic alterations. Here we present Sniffles2, which improves over current methods by implementing a repeat aware clustering coupled with a fast consensus sequence and coverage-adaptive filtering. Sniffles2 is 11.8 times faster and 29% more accurate than state-of-the-art SV callers across different coverages (5–50×), sequencing technologies (ONT and HiFi) and SV types. Furthermore, Sniffles2 solves the problem of family-level to population-level SV calling to produce fully genotyped VCF files. Across 11 probands, we accurately identified causative SVs around MECP2 , including highly complex alleles with three overlapping SVs. Sniffles2 also enables the detection of mosaic SVs in bulk long-read data. As a result, we identified multiple mosaic SVs in brain tissue from a patient with multiple system atrophy. The identified SV showed a remarkable diversity within the cingulate cortex, impacting both genes involved in neuron function and repetitive elements.

1 December 2008 in The Lancet Neurology
Verified
Journal Article
Closed access
SSSara Salinas
Sara Salinas
CPChristos Proukakis
Christos Proukakis
ACAndrew Crosby
Andrew Crosby
TWThomas T Warner
Thomas T Warner

12 March 2013 in Neurology
Verified
Journal Article
Closed access
PDF file
CPChristos Proukakis
Christos Proukakis
CDChristopher G. Dudzik
Christopher G. Dudzik
TBTimothy Brier
Timothy Brier
DMDonna S. MacKay
Donna S. MacKay
JCJ. Mark Cooper
J. Mark Cooper
ASAnthony Schapira
Anthony Schapira
Alpha-synuclein (SNCA) is central to the pathogenesis of Parkinson disease (PD), with 3 missense mutations reported to date. We report a novel mutation (p.H50Q) in a pathologically proven case.

12 February 2013 in Acta Neuropathologica
Verified
Journal Article
Open access
PDF file
AKAoife P. Kiely
Aoife P. Kiely
YAYasmine T. Asi
Yasmine T. Asi
EKEleanna Kara
Eleanna Kara
PLPatricia Limousin
Patricia Limousin
HLHelen Ling
Helen Ling
JHJanice L. Holton
Janice L. Holton
We report a British family with young-onset Parkinson’s disease (PD) and a G51D SNCA mutation that segregates with the disease. Family history was consistent with autosomal dominant inheritance as both the father and sister of the proband developed levodopa-responsive parkinsonism with onset in their late thirties. Clinical features show similarity to those seen in families with SNCA triplication and to cases of A53T SNCA mutation. Post-mortem brain examination of the proband revealed atrophy affecting frontal and temporal lobes in addition to the caudate, putamen, globus pallidus and amygdala. There was severe loss of pigmentation in the substantia nigra and pallor of the locus coeruleus. Neuronal loss was most marked in frontal and temporal cortices, hippocampal CA2/3 subregions, substantia nigra, locus coeruleus and dorsal motor nucleus of the vagus. The cellular pathology included widespread and frequent neuronal α-synuclein immunoreactive inclusions of variable morphology and oligodendroglial inclusions similar to the glial cytoplasmic inclusions of multiple system atrophy (MSA). Both inclusion types were ubiquitin and p62 positive and were labelled with phosphorylation-dependent anti-α-synuclein antibodies In addition, TDP-43 immunoreactive inclusions were observed in limbic regions and in the striatum. Together the data show clinical and neuropathological similarities to both the A53T SNCA mutation and multiplication cases. The cellular neuropathological features of this case share some characteristics of both PD and MSA with additional unique striatal and neocortical pathology. Greater understanding of the disease mechanism underlying the G51D mutation could aid in understanding of α-synuclein biology and its impact on disease phenotype.

22 February 2004 in Nature Genetics
Verified
Journal Article
Open access
PDF file
CWChristian Windpassinger
Christian Windpassinger
MAMichaela Auer-Grumbach
Michaela Auer-Grumbach
JIJoy Irobi
Joy Irobi
HPHeema Patel
Heema Patel
EPErwin Petek
Erwin Petek
KWKlaus Wagner
Klaus Wagner
Distal hereditary motor neuropathy (dHMN) or distal spinal muscular atrophy (OMIM #182960) is a heterogeneous group of disorders characterized by an almost exclusive degeneration of motor nerve fibers, predominantly in the distal part of the limbs1. Silver syndrome (OMIM #270685) is a rare form of hereditary spastic paraparesis mapped to chromosome 11q12–q14 (SPG17) in which spasticity of the legs is accompanied by amyotrophy of the hands and occasionally also the lower limbs2,3. Silver syndrome and most forms of dHMN are autosomal dominantly inherited with incomplete penetrance and a broad variability in clinical expression. A genome-wide scan in an Austrian family with dHMN-V (ref. 4) showed linkage to the locus SPG17, which was confirmed in 16 additional families with a phenotype characteristic of dHMN or Silver syndrome. After refining the critical region to 1 Mb, we sequenced the gene Berardinelli-Seip congenital lipodystrophy (BSCL2) and identified two heterozygous missense mutations resulting in the amino acid substitutions N88S and S90L. Null mutations in BSCL2, which encodes the protein seipin, were previously shown to be associated with autosomal recessive Berardinelli-Seip congenital lipodystrophy5 (OMIM #269700). We show that seipin is an integral membrane protein of the endoplasmic reticulum (ER). The amino acid substitutions N88S and S90L affect glycosylation of seipin and result in aggregate formation leading to neurodegeneration.

24 October 2004 in Nature Genetics
Verified
Journal Article
Closed access
MSMichael A Simpson
Michael A Simpson
HCHarold Cross
Harold Cross
CPChristos Proukakis
Christos Proukakis
DPDavid A Priestman
David A Priestman
DNDavid C A Neville
David C A Neville
ACAndrew H Crosby
Andrew H Crosby